For laboratory research use only. Not for human or animal consumption.
BioIntegrityResearch

Neurotropic & Cognitive

Selank

Tuftsin analog heptapeptide

Selank (tuftsin analogue heptapeptide)

Research context

Selank is derived from tuftsin, an endogenous immunomodulatory tetrapeptide, with a C-terminal PGP extension conferring degradation resistance. Research examines GABA receptor binding, interleukin transcript profiles, and enkephalinase activity in neural and immune preparations.

Common assays: GABA receptor binding · Interleukin transcript quantification · Enkephalinase activity

Specification

DesignationTuftsin analog heptapeptide
Full nameSelank (tuftsin analogue heptapeptide)
SequenceThr-Lys-Pro-Arg-Pro-Gly-Pro
CAS number129954-34-3
Molecular formulaC33H57N11O9
Molecular weight751.88 g/mol
Formats10 mL Vial · 15 mL Nasal Spray · 15 mL Oral Spray
SolubilitySterile water, bacteriostatic water
StorageLyophilised: −20 °C. Reconstituted: 2–8 °C.

Published literature

Selected peer-reviewed references describing research involving this compound. Listed for reference only; inclusion is not a claim about any outcome.

  1. Kozlovskii II, Danchev ND.The optimizing action of synthetic peptide Selank on a conditioned active avoidance reflex in ratsNeuroscience and Behavioral Physiology · 2003 Find on PubMed ↗
  2. Volkova A, Shadrina M, Kolomin T, et al.Selank administration affects the expression of some genes involved in GABAergic neurotransmissionFrontiers in Pharmacology · 2016 Find on PubMed ↗

Common questions

What is Selank derived from?

Tuftsin, a naturally occurring immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg), extended with proline-glycine-proline for stability.

How does Selank compare structurally to Semax?

Both are heptapeptides using the same Pro-Gly-Pro stabilising strategy, but with different parent sequences — Selank from tuftsin, Semax from ACTH(4-10).

Same pathway

Related compounds